Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia-Reference-Cited by-同舟云学术

Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia

Published:2014-08-28 Issue:4 Volume:4 Page:270-278
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Rossenu Stefaan¹,Cleton Adriaan¹,Hough David²,Crauwels Herta¹,Vandebosch An¹,Berwaerts Joris²,Eerdekens Marielle¹,Herben Virginie¹,De Meulder Marc¹,Remmerie Bart¹,Francetic Igor³

Affiliation:

1. Division of Janssen Pharmaceutica NV; Janssen Research & Development; Beerse Belgium

2. Janssen Research & Development; LLC; Raritan NJ USA

3. Institute of Clinical Pharmacology; Clinical Hospital Centre; Zagreb Croatia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference29 articles.

1. Schizophrenia: a concise overview of incidence, prevalence, and mortality;McGrath;Epidemiol Rev.,2008

2. Partial compliance and patient consequences in schizophrenia: our patients can do better;Keith;J Clin Psychiatry.,2003

3. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia;Bhanji;Eur Neuropsychopharmacol.,2004

4. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention;Agid;Expert Opin Pharmacother.,2010

5. Extended-release intramuscular paliperidone palmitate: a review of its use in the treatment of schizophrenia;Carter;Drugs.,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paliperidone poisoning and measurable plasma concentrations 2.5 years after last administered dose: A case report;British Journal of Clinical Pharmacology;2024-03-07

2. Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs;CPT: Pharmacometrics & Systems Pharmacology;2024-03

3. Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic Relapse;Schizophrenia Bulletin;2023-10-05

4. Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches;Expert Opinion on Pharmacotherapy;2023-06-27

5. Predictors of everyday functional impairment in older patients with schizophrenia: A cross-sectional study;Frontiers in Psychiatry;2023-01-18